JP2024026191A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024026191A5 JP2024026191A5 JP2023200433A JP2023200433A JP2024026191A5 JP 2024026191 A5 JP2024026191 A5 JP 2024026191A5 JP 2023200433 A JP2023200433 A JP 2023200433A JP 2023200433 A JP2023200433 A JP 2023200433A JP 2024026191 A5 JP2024026191 A5 JP 2024026191A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid sequence
- virus strain
- vaccinia virus
- chimeric poxvirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025016649A JP2025072482A (ja) | 2016-08-09 | 2025-02-04 | キメラポックスウイルス組成物及びその使用 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662372408P | 2016-08-09 | 2016-08-09 | |
| US62/372,408 | 2016-08-09 | ||
| US201762519010P | 2017-06-13 | 2017-06-13 | |
| US62/519,010 | 2017-06-13 | ||
| PCT/US2017/046163 WO2018031694A1 (en) | 2016-08-09 | 2017-08-09 | Chimeric poxvirus compositions and uses thereof |
| JP2019507161A JP7023929B2 (ja) | 2016-08-09 | 2017-08-09 | キメラポックスウイルス組成物及びその使用 |
| JP2022017693A JP7395628B2 (ja) | 2016-08-09 | 2022-02-08 | キメラポックスウイルス組成物及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017693A Division JP7395628B2 (ja) | 2016-08-09 | 2022-02-08 | キメラポックスウイルス組成物及びその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025016649A Division JP2025072482A (ja) | 2016-08-09 | 2025-02-04 | キメラポックスウイルス組成物及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024026191A JP2024026191A (ja) | 2024-02-28 |
| JP2024026191A5 true JP2024026191A5 (enExample) | 2024-08-05 |
| JP7631485B2 JP7631485B2 (ja) | 2025-02-18 |
Family
ID=61163330
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019507161A Active JP7023929B2 (ja) | 2016-08-09 | 2017-08-09 | キメラポックスウイルス組成物及びその使用 |
| JP2022017693A Active JP7395628B2 (ja) | 2016-08-09 | 2022-02-08 | キメラポックスウイルス組成物及びその使用 |
| JP2023200433A Active JP7631485B2 (ja) | 2016-08-09 | 2023-11-28 | キメラポックスウイルス組成物及びその使用 |
| JP2025016649A Pending JP2025072482A (ja) | 2016-08-09 | 2025-02-04 | キメラポックスウイルス組成物及びその使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019507161A Active JP7023929B2 (ja) | 2016-08-09 | 2017-08-09 | キメラポックスウイルス組成物及びその使用 |
| JP2022017693A Active JP7395628B2 (ja) | 2016-08-09 | 2022-02-08 | キメラポックスウイルス組成物及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025016649A Pending JP2025072482A (ja) | 2016-08-09 | 2025-02-04 | キメラポックスウイルス組成物及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12084687B2 (enExample) |
| EP (1) | EP3497209A4 (enExample) |
| JP (4) | JP7023929B2 (enExample) |
| KR (3) | KR20250067190A (enExample) |
| CN (3) | CN118834840A (enExample) |
| AU (3) | AU2017311380A1 (enExample) |
| CA (1) | CA3033512A1 (enExample) |
| MX (1) | MX2019001672A (enExample) |
| RU (2) | RU2021128158A (enExample) |
| WO (1) | WO2018031694A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2934532B1 (en) | 2012-12-20 | 2019-10-23 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| EP4122492A1 (en) | 2015-02-25 | 2023-01-25 | Memorial Sloan Kettering Cancer Center | Use of inactivated nonreplicating modified vaccinia virus ankara (mva)as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors |
| KR20180006916A (ko) | 2015-04-17 | 2018-01-19 | 메모리얼 슬로안-케터링 캔서 센터 | 고형 종양에 대한 면역치료제로서 mva 또는 mva델타e3l의 용도 |
| WO2017147554A2 (en) | 2016-02-25 | 2017-08-31 | Memorial Sloan-Kettering Cancer Center | Recombinant mva or mvadele3l expressing human flt3l and use thereof as immuno-therapeutic agents against solid tumors |
| CN109152815B (zh) | 2016-02-25 | 2022-10-18 | 纪念斯隆凯特琳癌症中心 | 用于癌症免疫治疗的具有胸苷激酶缺失和具有或不具有人flt3l或gm-csf表达的复制型减毒痘苗病毒 |
| CA3019835A1 (en) | 2016-04-08 | 2017-10-12 | Purdue Research Foundation | Methods and compositions for car t cell therapy |
| KR20250067190A (ko) * | 2016-08-09 | 2025-05-14 | 시티 오브 호프 | 키메라 폭스바이러스 조성물 및 이의 용도 |
| CN110582288B (zh) | 2017-02-28 | 2024-09-20 | 恩多塞特公司 | 用于car t细胞疗法的组合物和方法 |
| CN111107872A (zh) | 2017-05-12 | 2020-05-05 | 纪念斯隆-凯特林癌症中心 | 有用于癌症免疫疗法的牛痘病毒突变体 |
| CN111163803B (zh) | 2017-08-11 | 2025-05-09 | 希望之城公司 | 表达car t细胞靶物的溶瘤病毒及其用途 |
| WO2019144095A1 (en) | 2018-01-22 | 2019-07-25 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Methods of use for car t cells |
| JP7568224B2 (ja) | 2018-02-23 | 2024-10-16 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞療法のための配列決定法 |
| CA3093093A1 (en) * | 2018-03-07 | 2019-09-12 | Transgene | Parapoxvirus vectors |
| WO2019213173A1 (en) * | 2018-04-30 | 2019-11-07 | City Of Hope | Neural stem cell compositions including chimeric poxviruses for cancer treatment |
| CA3112654A1 (en) | 2018-09-15 | 2020-03-19 | Memorial Sloan Kettering Cancer Center | Recombinant poxviruses for cancer immunotherapy |
| CN113583977B (zh) * | 2020-04-30 | 2025-06-06 | 杭州康万达医药科技有限公司 | 可受微小rna调控的分离的重组溶瘤痘病毒及其应用 |
| GB2614309A (en) | 2021-12-24 | 2023-07-05 | Stratosvir Ltd | Improved vaccinia virus vectors |
| WO2023213763A1 (en) * | 2022-05-02 | 2023-11-09 | Transgene | Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab |
| KR20250052416A (ko) | 2022-08-18 | 2025-04-18 | 트랜스진 | 키메라 폭스바이러스 |
| WO2024245722A2 (en) * | 2023-05-26 | 2024-12-05 | Probiogen Ag | Rapid selection system for the generation of recombinant enveloped viruses |
| US12698512B2 (en) | 2023-11-06 | 2026-08-04 | City Of Hope | Methods comprising oncolytic viruses expressing CD19T and bispecific T cell engagers |
| WO2025184411A1 (en) | 2024-02-27 | 2025-09-04 | Calidi Biotherapeutics (Nevada), Inc. | Serum-resistant eev viruses and uses thereof |
| WO2026107113A1 (en) | 2024-11-12 | 2026-05-21 | Calidi Biotherapeutics (Nevada), Inc. | MODIFIED CELLS FOR PROGRAMMING EXTRA ENVELOPED VIRUSES (EEVs) AND THEIR USE FOR PRODUCING THE EEVs, THE PROGRAMMED EEVs AND USES THEREOF |
| CN120718864B (zh) * | 2025-08-28 | 2025-11-28 | 山东农业大学 | 一种高度不成熟鸭坦布苏病毒及其培养方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT406376B (de) | 1998-01-16 | 2000-04-25 | Immuno Ag | Chimäres poxvirus enthaltend eine retrovirale vektorkomponente |
| JP2003528605A (ja) | 2000-03-28 | 2003-09-30 | ユニヴァーシティー オヴ ロチェスター | ライブラリーを作成する方法および目的のポリヌクレオチドを選択する方法 |
| ATE365220T1 (de) * | 2002-11-25 | 2007-07-15 | Bavarian Nordic As | Mindestens zwei ati promotoren enthaltendes rekombinantes pockenvirus |
| MXPA05013879A (es) * | 2003-06-18 | 2006-06-27 | Genelux Corp | Virus de la vaccinia recombinantes modificados y otros microorganismos, y usos de los mismos. |
| EP2415783B1 (en) * | 2006-10-16 | 2016-12-14 | Genelux Corporation | Modified vaccinia virus strains for use in a diagnostic and therapeutic method |
| EP2212423B1 (en) * | 2007-11-19 | 2015-02-11 | Transgene SA | Poxviral oncolytic vectors |
| JP5652830B2 (ja) | 2010-04-09 | 2015-01-14 | 国立大学法人 東京大学 | マイクロｒｎａ制御組換えワクシニアウイルス及びその使用 |
| EP2697368B1 (en) | 2011-04-15 | 2019-06-05 | Genelux Corporation | Clonal strains of attenuated vaccinia viruses and methods of use thereof |
| NZ701949A (en) * | 2012-05-18 | 2016-07-29 | Otago Innovation Ltd | Combination treatments and compositions for wound healing |
| WO2015103438A2 (en) * | 2014-01-02 | 2015-07-09 | Genelux Corporation | Oncolytic virus adjunct therapy with agents that increase virus infectivity |
| KR20250067190A (ko) * | 2016-08-09 | 2025-05-14 | 시티 오브 호프 | 키메라 폭스바이러스 조성물 및 이의 용도 |
-
2017
- 2017-08-09 KR KR1020257014373A patent/KR20250067190A/ko active Pending
- 2017-08-09 AU AU2017311380A patent/AU2017311380A1/en not_active Abandoned
- 2017-08-09 US US16/324,541 patent/US12084687B2/en active Active
- 2017-08-09 MX MX2019001672A patent/MX2019001672A/es unknown
- 2017-08-09 RU RU2021128158A patent/RU2021128158A/ru unknown
- 2017-08-09 EP EP17840232.7A patent/EP3497209A4/en active Pending
- 2017-08-09 KR KR1020237024342A patent/KR20230113832A/ko not_active Ceased
- 2017-08-09 CN CN202410528486.XA patent/CN118834840A/zh active Pending
- 2017-08-09 CN CN201780062335.8A patent/CN110199018B/zh active Active
- 2017-08-09 JP JP2019507161A patent/JP7023929B2/ja active Active
- 2017-08-09 RU RU2019106319A patent/RU2757002C2/ru active
- 2017-08-09 KR KR1020197006987A patent/KR102557818B1/ko active Active
- 2017-08-09 CN CN202410528631.4A patent/CN118853594A/zh active Pending
- 2017-08-09 CA CA3033512A patent/CA3033512A1/en active Pending
- 2017-08-09 WO PCT/US2017/046163 patent/WO2018031694A1/en not_active Ceased
-
2022
- 2022-02-08 JP JP2022017693A patent/JP7395628B2/ja active Active
-
2023
- 2023-11-20 AU AU2023270200A patent/AU2023270200B2/en active Active
- 2023-11-28 JP JP2023200433A patent/JP7631485B2/ja active Active
-
2024
- 2024-07-17 US US18/776,109 patent/US20250084384A1/en active Pending
-
2025
- 2025-02-04 JP JP2025016649A patent/JP2025072482A/ja active Pending
-
2026
- 2026-05-05 AU AU2026203424A patent/AU2026203424A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025072482A5 (enExample) | ||
| RU2019106319A (ru) | Композиции химерного поксвируса и их применение | |
| JP2022065034A5 (enExample) | ||
| JP2019524131A5 (enExample) | ||
| MX2023002945A (es) | Moléculas multiespecíficas con direccionamiento inmunitario y usos de estas. | |
| Chen et al. | Androgen pathway stimulates microRNA‐216a transcription to suppress the tumor suppressor in lung cancer‐1 gene in early hepatocarcinogenesis | |
| Nakatani et al. | Isolation of an amplified DNA sequence in stomach cancer | |
| JP2021524275A5 (enExample) | ||
| KR20170018450A (ko) | 세포 치료제로서의 car-발현 nk-92 세포 | |
| JP2018523484A5 (enExample) | ||
| JP2014207903A5 (enExample) | ||
| JP2021524270A5 (enExample) | ||
| JP2022521486A5 (enExample) | ||
| JP2010503413A5 (enExample) | ||
| JP2022538375A5 (enExample) | ||
| JP2018520669A5 (enExample) | ||
| RU2019112725A (ru) | Композиции и способы для повышения стабильности трансгенов в поксвирусах | |
| Mathijs et al. | Complete coding sequence of a lumpy skin disease virus strain isolated during the 2016 outbreak in Kazakhstan | |
| JP2021525770A5 (enExample) | ||
| JP2024517855A5 (enExample) | ||
| WO2023122882A1 (zh) | 双特异性t细胞衔接器、其重组溶瘤病毒及其用途 | |
| JP6235697B2 (ja) | 変異ワクシニアウイルス株、その使用およびそれを作製する方法 | |
| EP4573113A1 (en) | Chimeric poxviruses | |
| CN103484462B (zh) | Survivin启动子调控CD基因的重组腺病毒载体构建及其应用 | |
| CN105112412B (zh) | 用于敲除人BTF基因的gRNA序列及其敲除方法 |